Showing results (231-240 of 304) with videos related to

Sort By:
Pageof 31
BMC Plant Biology|December 6, 2014
Evaluation and integration of functional annotation pipelines for newly sequenced organisms: the potato genome as a test caseDavid Amar, Itziar Frades, Agnieszka Danek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 19, 2016
Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertensionLaurent Godinas, David Amar, David Montani, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 31, 2012
Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgeryDavid Amar, Hao Zhang, Weiji Shi, et al.
International Journal of Surgery (London, England)|August 7, 2023
Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: a case seriesThomas Boerner, Rebecca Carr, Meier Hsu, et al.
BJS Open|January 18, 2022
Primary lung cancer in women after previous breast cancerTamar B Nobel, Rebecca A Carr, Raul Caso, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 24, 2024
High-risk features associated with recurrence in stage I lung adenocarcinomaCameron N Fick, Elizabeth G Dunne, Stijn Vanstraelen, et al.
JTO Clinical and Research Reports|July 21, 2022
Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term OutcomesJennie K Choe, Amy Zhu, Alexander J Byun, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 7, 2025
Surgical Outcomes Using Three-Dimensional Image Simulation for Segmentectomy Planning in Patients with Stage IA1-2 Non-Small Cell Lung CancerStella T Tsui, Kay See Tan, Junting Zheng, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 31, 2025
Lobectomy Improves Disease-Free Survival Over Sublobar Resection for High-Risk Stage IA Non-Small Cell Lung CancerRaul Caso, Nanruoyi Zhou, Matthew Skovgard, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2026
Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancersNanruoyi Zhou, Stella Tsui, Nicolas Toumbacaris, et al.
Pageof 31